Arrowhead Research reported $384.6M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Anika Therapeutics ANIK:US $ 165.78M 11.98M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Cerulean Pharma CERU:US $ 48.24M 34.18M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Ligand Pharmaceuticals LGND:US $ 432.08M 21.18M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Novartis NOVN:VX 26.25B 2.45B
Opko Health OPK:US $ 557.51M 10.48M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Spectrum Pharmaceuticals SPPI:US $ 140M 25.71M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Xencor XNCR:US $ 329.63M 151.34M
YTE INCY:US $ 2923.8M 303.74M